See also this year's filing and all EDGAR filings for this company.
PDF Report 0001423824_2019_Alder_Biopharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Regenerx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001423824, Alder Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 419,809,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,400,000 |
| 3 | remainder_Assets | 30,000 |
| 4 | LiabilitiesCurrent | 28,236,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 184,272,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 71,458,019 |
| 9 | ResearchAndDevelopmentExpense | 227,945,208 |
| 10 | remainder_Expenses | 1,592,110 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -5,029,518 |
| 13 | remainder_ComprehensiveNetIncome | -745,149 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 426,239,000 |
| 1 | Liabilities | 212,508,000 |
| 2 | Expenses | 300,995,337 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 213,731,000 |
| 5 | NetIncome | -306,024,855 |
| 6 | ComprehensiveNetIncome | -306,397,430 |
| 7 | BaseVar | 472,758,502 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.500 |
| 9 | EconomicCapitalRatio | 1.88 |
Edgar->Model Mapping
Feature Distribution
Change over Time
